Ascentage Pharma (6855.HK) founded in 2009, is a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and age-related diseases. The company aims to discovery and development of innovative first- and best-in-class therapies to address unmet medical needs globally. Learn More
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed